Placebo to match 10 mg, Placebo to match 5 mg
CB8025-41837
Phase 3 small_molecule active
Quick answer
Placebo to match 10 mg, Placebo to match 5 mg for Primary Biliary Cholangitis is a Phase 3 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- Primary Biliary Cholangitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active